Diclofenamidum [Inn-Latin] en es it fr

Diclofenamidum [Inn-Latin] Brand names, Diclofenamidum [Inn-Latin] Analogs

Diclofenamidum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Diclofenamidum [Inn-Latin] Chemical_Formula

C6H6Cl2N2O4S2

Diclofenamidum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic/dichlorphen.htm

Diclofenamidum [Inn-Latin] fda sheet

Diclofenamidum [Inn-Latin] msds (material safety sheet)

Diclofenamidum [Inn-Latin] Synthesis Reference

No information avaliable

Diclofenamidum [Inn-Latin] Molecular Weight

305.16 g/mol

Diclofenamidum [Inn-Latin] Melting Point

228.7 oC

Diclofenamidum [Inn-Latin] H2O Solubility

No information avaliable

Diclofenamidum [Inn-Latin] State

Solid

Diclofenamidum [Inn-Latin] LogP

0.37

Diclofenamidum [Inn-Latin] Dosage Forms

No information avaliable

Diclofenamidum [Inn-Latin] Indication

For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure

Diclofenamidum [Inn-Latin] Pharmacology

Dichlorphenamide is an oral carbonic anhydrase inhibitor indicated for adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Carbonic anhydrase inhibitors reduce intraocular pressure by partially suppressing the secretion of aqueous humor (inflow).

Diclofenamidum [Inn-Latin] Absorption

No information avaliable

Diclofenamidum [Inn-Latin] side effects and Toxicity

No information avaliable

Diclofenamidum [Inn-Latin] Patient Information

No information avaliable

Diclofenamidum [Inn-Latin] Organisms Affected

Humans and other mammals